To validate that repression of IRF2, POU2F1, and other TFs are driving immune exclusion in β-catenin-mutated HCC, we first overexpressed either pT3 (empty vector) or Irf2 (β-M-IRF2) in the β-M model (Figure 5e). The gene discussed is IRF2; the disease is hepatocellular carcinoma.